Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?

Arch Intern Med. 1997 Dec;157(22):2550-6.

Authors

J E Dalen¹, J S Alpert, J Hirsh

Affiliation

¹ Department of Medicine, The University of Arizona College of Medicine, Tucson 85724-5018, USA.

PMID: 9531222

No abstract available

Publication types

Review

MeSH terms

Acute Disease
Anticoagulants / therapeutic use
Heparin / therapeutic use
Humans
Patient Selection
Plasminogen Activators / therapeutic use*
Pulmonary Embolism / drug therapy*
Pulmonary Embolism / mortality
Randomized Controlled Trials as Topic
Recombinant Proteins / therapeutic use
Recurrence
Streptokinase / therapeutic use
Thrombolytic Therapy* / adverse effects
Thrombolytic Therapy* / standards
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use

Substances

Anticoagulants
Recombinant Proteins
Heparin
Streptokinase
Plasminogen Activators
Tissue Plasminogen Activator
Urokinase-Type Plasminogen Activator